Reinhard Lissner is a notable inventor based in Gonz-Weilbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases related to LPS and apoptosis regulation. With a total of 3 patents, Lissner's work has the potential to impact many lives.

Latest Patents

Lissner's latest patents include a pharmaceutical composition designed for the treatment of diseases where LPS and/or apoptosis regulation is disturbed. This innovative composition incorporates colostrum and vitamin D, showcasing his commitment to developing effective therapeutic solutions. Another significant patent involves the oral administration of immunoglobulin preparations derived from plasma, colostral milk, milk, eggs, or cell cultures. This invention aims to provide therapy and prophylaxis for patients suffering from heavy therapy-refractory pain conditions, even in the absence of typical pathological anatomical correlates.

Career Highlights

Throughout his career, Reinhard Lissner has worked with various companies, including Biotest Pharma GmbH. His experience in the pharmaceutical industry has allowed him to develop groundbreaking solutions that address complex medical challenges.

Collaborations

Lissner has collaborated with notable professionals in his field, including Wolfgang Moller and Dietrich Nitsche. These partnerships have likely contributed to the advancement of his innovative ideas and patents.

Conclusion

Reinhard Lissner's contributions to pharmaceutical innovation demonstrate his dedication to improving healthcare through research and development. His patents reflect a deep understanding of complex medical issues and a commitment to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com